Recent advances in the surgical treatment of pancreatic cancer

INTRODUCTIONPancreatic cancer remains the fourth commonest cause of cancer related death in the western world[1]. The prognosis remains dismal due partly to late presentation, with associated low resectability rates, and the aggressive biological nature of these tumors. The median survival time from diagnosis in unresectable tumors remains only 4 6 months.For those patients amenable to surgical resection over the last 20 years have seen marked improvements in postoperative mortality and morbidity, especially in specialist pancreatic centres 23. Despite these changes long-term survival remains low. with a total 5-year survival rate remaining less than 5%.Patients with ampullary cancer have a better 5-year survival of 40°%-60°%.

Surgical Treatment of Carcinoma of Esophagus and Gastric Cardia—A 34—year Investigation

Objective To understand the progress in surgical treatment of 12 970 patients with carcinoma of esophagus and gastric cardiac during 1965-1998.Methods The patients were divided into A, B and C groups: 3 155 patients (group A) were treated surgically in the first 14 years, 5952 patients (group B) in the next 10 years, and 3 863 patients (group C) in the last 10 years. The early stage lesions (Tis, Tl) were assigned as a separate group. The results of these groups were compared.Results The resectability for esophageal and gastric cardiac carcinoma was 94.0% and 84.4% respectively, and the overall resectability was 91.3% . The resectabih'ty for groups A, B, C and the early stage group was 82.1% , 85.1% , 90.2% and 100% , respectively. The overall operative mortality was 1.8%, it was 4.4% for group A, 1.6% for group B, and 0.5% for group C. The overall 5-year survival was 31.6% . The 5-year survival for groups A, B, C and the early stage group was 27.0% , 29.1%, 32.0% and 92.6%, respectively . Among the 3 temporal groups, differences were observed in terms of lesion stage, location and size, surgery with or without combined therapy and postoperative complications.Conclusion Best results were achieved in the early cases, with a resectability of 100% and a 5-year survival of 92.6% . The indications for surgical treatment were extended with increased resectability and decreased mortality. Subtotal esophagectomy combined with cervical esophagogastrostomy was advocated as the procedure of first choice for esophageal carcinoma in attempt to diminish the chance of recurrence, and to achieve better outcomes by using combined therapy for patients with e" stage b! lesion.

Radiotherapy combined with surgical treatment for gastric cancer:a meta-analysis

Objective:We carried out a meta-analysis to assess the effectiveness and safety of radiotherapy combined with surgery for gastric cancer.Methods:Randomized Clinical Trials (RCTs) in which radiotherapy (preoperative,intraoperative and postoperative),was compared with surgery alone in resectable gastric cancer were identified by searching Cochrane Library (Issue 2,2009),PubMed (Jan 1966-Jun 2009),EMBASE (Jan 1974-Jun 2009),Chinese Biomedical Literature Database (Jan 1978-Jun 2009),Chinese Science and Technology Periodicals Database (Jan 1989-Jun 2009),China National Knowledge Infrastructure (Jan 1994-Jun 2009) and Wanfang database (Jan 1997-Jun 2009) in English and Chinese languang.Two researchers assessed the quality of included randomized controlled trials (RCT) extracted data independently.The RevMan 5.0 software was used for meta-analysis.Our researchers assessed the quality of included randomized controlled trials (RCT) extracted data independently.The RevMan 5.0 software was used for meta-analysis.Results:Nine randomized controlled trials of 1 548 patients were selected for meta-analysis.Five randomized controlled trials were related with comparison of preoperative radiotherapy plus surgery with single surgery.Two randomized controlled trials were the comparative studies between surgery plus postoperative and single surgery.The meta-analysis results showed that:(1) compared with surgery alone,preoperative radiotherapy combined with surgery can increase 3 years (OR=1.78;95% CI 1.14-2.78,P=0.01),5 years (OR=1.67;95% CI 1.22-2.29,P=0.001),10 years (OR=1.64;95% CI 1.03-2.60,P=0.04) survival rate and resection rate (OR=2.15;95% CI 1.31-3.54,P=0.003);reduce the of tumor recurrence rate (OR=0.59;95% CI 0.37-0.92,P=0.02) and metastasis rate (OR=0.44;95% CI 0.27-0.73,P=0.001);(2) The tumor recurrent rates (OR=0.19,95% CI 0.03-1.14,P=0.07) and tumor metastasis rate (OR=0.09;95% CI 0.00-1.77,P=0.11) had no difference between single surgery group and peri-operative radiotherapy plus surgery group;(3) Postoperative radiotherapy compared with surgery alone had no significant effects on 1 year (OR=0.83;95% CI 0.60-1.15,P=0.26) and 3 years (OR=0.75;95% CI 0.51-1.11,P=0.15) survival rate compared with single surgery,but the 5-year survival rates (OR=0.57;95% CI 0.34-0.95,P=0.03) of the patients who received surgery alone was higher than those who received combined therapy.No difference of the tumor recurrence rate (OR=0.59;95% CI 0.33-1.05,P=0.07),tumor metestasis rate (OR=0.90;95% CI 0.51-1.59,P=0.71) and anastomotic leak (OR=0.98;95% CI 0.25-3.65,P=0.98) were observed between the two groups.Conclusion:Preoperative radiotherapy combined surgery is more rational and effective than surgery alone of gastric cancer.However,in terms of the clinical effects of perioperarive or postoperative radoiotherapy combined with surgery,much multicenter,largescale,high-quality,double-blind and rigorously designed studies would be needed than currently available in the future.

Application of mastoscopic in modified radical operation for preserving nipple-areolar complex

Objective: To probe the effect of mastoscopic in modified radical mastectomy operation for preserving nipple-areolar complex in the treatment of breast cancer. Methods: Thirty patients, with breast cancer of a diameter≤3 cm and a distance≥3 cm from the mammary areola were treated by mastoscopic from November 2003 to August 2006. After the lipoly- sis and suction of axillary fat, mastoscopic axillary lymph node dissection was performed. Results: The average operation time was 128.9 min (120–156 min), the intraoperative blood loss was 56 mL (30–100 mL). The mean lymph nodes harvested by endoscopy were 16 (6–34). Excellent cosmetic outcomes were obtained with symmetrical breast development and all the patients were satisfied with the treatment. Postoperative follow-up for 2–29 months (mean, 16.6 months) found no local recur-rence. Conclusion:This model of operation can protect the upper limb function and has value of aesthetics of the brisket. What’s more, improve the quality of survive of the patients.

Surgical treatment effects in cancer of the cardia and esophagogastric junction

Objective： To evaluate the treatment effects of total gastrectomy （TG） and proximal gastrectomy （PG） for cancer of the cardia and esophagogastric junction. Methods： forty-five patients with cancer of the cardia and esophagogastric junction underwent surgical resection. Of them, 29 were treated using proximal gastrectomy and 16 total gastrectomy. The 3-year and 5-year survival rate and the postoperative complication rate and mortality rate were followed up and compared between the two groups. Results： The 3-year and 5-year survival rates of group PG were 44.8% and 20.7%, of group TG were 37.5% and 18.8%, respectively, and the differences were not statistically significant （X^2= 3.84, P 〉 0.05; X^2= 3.89, P 〉 0.05）. The postoperative complication and mortality rate of group PG were 13.7% and 6.8%, of group TG was all 6%, respectively. Conclusion： Proximal and total gastrectomy treatment effects can not significantly influence the prognosis of patients in progressive stage of cancer of cardia and esophagogastric junction.

神经内分泌肿瘤肝转移的外科干预策略

神经内分泌肿瘤是一组较罕见的肿瘤性疾病,可发生于身体多种脏器,具有高度肿瘤异质性,常形成以肝脏为最主要受累器官的继发性肿瘤并伴发类癌综合征。肝转移是造成神经内分泌肿瘤患者治疗失败的重要临床事件,通过及时、合理的外科干预有效控制病情发展、争取达到肿瘤无病状态或根治目标,有效延长患者总体生存,是近年来临床医师和研究者聚焦的重要课题。本文综合近年来国内外神经内分泌肿瘤肝转移的外科治疗策略和我国最新诊治指南,并结合笔者实际临床工作经验进行综述和讨论。

海信CAS辅助下高强度聚焦超声消融治疗晚期胰腺癌效果

目的探讨海信计算机辅助系统(CAS)辅助下高强度聚焦超声(HIFU)治疗胰腺癌的效果。方法选取2020年1月-2021年5月于我院拟行HIFU治疗的22例胰腺癌患者。术前采用海信CAS将二维CT图像进行三维重建,明确胰腺肿瘤与周围肠道、脏器的毗邻关系,通过实体瘤疗效评价标准评价局部消融疗效,并记录患者术后并发症发生情况。结果海信CAS数字化三维重建结果可清晰显示胰腺肿瘤与周围肠道、脏器的毗邻关系,协助实现精准消融。22例胰腺癌患者中完全缓解率为9.1%,部分缓解率为68.2%,疾病稳定率为13.6%,疾病进展率为9.1%。所有患者在HIFU术后均未出现胃肠道穿孔、急性胰腺炎、胰瘘及消化道出血等严重并发症,仅1例患者出现浅Ⅱ度皮肤灼伤。结论海信CAS辅助下HIFU治疗晚期胰腺癌效果较好,值得在临床推广。

不同免充气腔镜术式治疗甲状腺癌的效果比较

目的比较免充气经口腔前庭入路与免充气经腋窝入路对腔镜治疗甲状腺癌效果的影响。方法回顾性分析2019年1月至2023年6月中国科学技术大学附属第一医院西区(安徽省肿瘤医院)收治的95例单侧甲状腺癌患者的临床资料,其中45例患者选自同期行经腋窝入路腔镜手术患者,50例选自同期行经口腔前庭腔入路腔镜手术患者。比较2种手术方式的疗效。结果2组患者在手术时间、术中出血量、住院时间、术后3 d引流量、术后并发症及美容满意度方面比较,差异无统计学意义(P>0.05);经口腔前庭组中央区淋巴结清扫数目多于经腋窝组(P<0.05)。结论经口腔前庭入路腔镜甲状腺手术体表无瘢痕较经腋窝入路腔镜手术在中央区淋巴结清扫上更有优势。

Clinical Experience of Primary Retroperitoneal Tumor: Report of 600 Cases

Objective： To summarize the experience of management for primary retroperitoneal tumor （PRPT） and to analyze the factors influencing the outcome after operation. Methods： The data of 600 cases of PRPT in General Hospital of PLA were reviewed retrospectively. Results： Of 600 cases of PRPT, 546 were surgically treated. Among theme 369 were malignant and 177 benign. 366 cases were followed up for 1 month to 15 years. The 1-years 3-year, and 5-year survival rate in the patients subject to complete resection was 90.5%, 73.2% and 53.6%, respectively, and that in incomplete resection patients was 70.6%, 32.0%, 5.7% respectively （P〈0.01）. The Cox multi-various regression analysis revealed showed completeness of tumor resection, sex and histologic type were associated closely with local recurrence. Conclusion： Sufficient preoperative preparation and complete tumor resection play important roles for reducing recurrence and improving survival.

浅表食管癌内镜黏膜下剥离术与外科手术疗效对比的研究进展

浅表食管癌(SEC)的传统治疗以内镜治疗和外科手术治疗为主。外科手术是食管肿瘤治疗的标准方法,但其围手术期并发症发生率和病死率均较高。近年来,内镜黏膜下剥离术已取得较大进展,为SEC患者提供了有效的诊断和治疗方法。本文就SEC内镜黏膜下剥离术与外科手术的疗效对比和超出内镜黏膜下剥离术适应证的SEC的治疗策略作一综述,以期提高临床医师对SEC治疗的认知。

MR多模态成像在直肠癌TN分期及手术方式选择中的应用

目的探讨MR多模态成像在直肠癌TN分期及手术方式选择中的应用价值。方法回顾性分析我院2020年1月—2022年5月396例直肠癌患者的MR征象,以此进行术前TN分期并模拟制定手术方式,分析手术前后TN分期的准确性,并比较拟定手术方式与实际手术方式的一致性。结果MR多模态成像辅助术前拟定直肠癌T分期的符合率为90.15%,与术后病理结果的一致性较高(K=0.82,P<0.01),且对于T2~T4分期的诊断准确率较高;N分期的符合率为71.46%,与术后病理结果的一致性适中(K=0.53,P<0.01)。MR多模态成像辅助拟定手术方式的符合率为89.14%,与实际术式一致性较高(K=0.79,P<0.01),且对于直肠癌各种术式拟定的准确率均较高。结论MR多模态成像对直肠癌的术前TN分期以及手术方式的制定有较高的临床价值。

原发性腹膜后平滑肌肉瘤初次术后影响生存期的因素分析

目的分析初次手术后对原发性腹膜后平滑肌肉瘤患者生存期的影响因素,并了解其临床特征。方法搜集2018年1月—2023年1月67例原发性腹膜后平滑肌肉瘤患者的临床资料进行回顾性分析。根据患者的手术情况、年龄、性别、病理类型及其他相关因素,对其生存期进行统计和分析。符合正态分布的计量资料以xˉ±s表示、采用t检验;计数资料以%表示、采用χ2检验。对影响患者预后因素的分析采用单因素分析,其中差异有统计学意义的因素采用多因素Logistic回归分析。结果67例患者的平均生存期为(18.25±2.41)个月,病理证实肿瘤类型均为平滑肌肉瘤。生存分析显示,年龄>60岁、肿瘤最大径>10 cm、肿瘤分期Ⅲ~Ⅳ期、肿瘤分化程度低~差、肿瘤累及其他脏器均是影响患者术后生存期的危险因素(P均<0.05);性别、体质量指数、吸烟史、饮酒史、手术方式对患者的生存期无明显影响(P均>0.05)。经多因素Logistic回归分析,表明年龄≥60岁、显微镜下切缘看到肿瘤细胞(R1切除)、肿瘤最大径≥10 cm、肿瘤分期Ⅲ~Ⅳ期、肿瘤低~差分化、肿瘤累及其他脏器均是影响原发性腹膜后平滑肌肉瘤初次手术后生存率的独立危险因素。结论患者年龄、肿瘤最大径、肿瘤分期等是影响患者预后的主要因素,准确评估这些影响因素有助于指导临床决策,进一步改善患者的预后结果。

《肿瘤外科学年鉴:肝外胆管癌和胆囊癌临床诊疗指南》推荐意见

胆道恶性肿瘤是一类发病率低但侵袭性强的消化道肿瘤,主要包括肝内胆管癌、肝外胆管癌和胆囊癌,常常伴随着局部进展或远处转移等特征。对于局部可切除的患者而言,手术往往是首选的治疗方法。然而,即便患者接受根治性手术其术后复发风险依然很高。因此,对于胆道恶性肿瘤患者而言,通常需要采取多种治疗模式,包括手术切除、全身治疗(如靶向治疗、化学治疗、免疫治疗)以及/或局部治疗的综合方案。随着胆道恶性肿瘤领域的逐渐发展,对于外科肿瘤学家而言,了解并掌握最新的外科诊疗策略以及最佳患者的选择和管理体系至关重要。鉴于治疗的复杂性和诊疗技术不断发展的特点,美国肿瘤外科学权威期刊《肿瘤外科学年鉴》于近期发表了关于肝胆肿瘤的实践诊疗指南,主要包括肝细胞癌、肝内胆管癌、肝外胆管癌和胆囊癌,旨在为肝胆肿瘤患者的临床管理和决策制定提供更多基于循证医学的证据。限于篇幅和不同侧重点,本文着重介绍该指南中关于肝外胆管癌和胆囊癌的评估要点和临床治疗的相关建议,以供临床参考。

Analysis on relative factors of lymph node metastasis and pattern of postoperative locoreginal relapse of esophageal carcinoma

Objective: We aimed to study the relative factors of lymph node metastasis of esophageal carcinoma, and to analyze the distribution rule of lymph node metastasis of post esophagectomy patients for guiding the radiotherapy. Methods: To collect the patients' data (102 cases) in our hospital from 2001 to 2009, who were found lymph node metastasis confirmed by pathologic in a certain period of time after esophageal cancer surgery. The factors affected the lymph node metastasis in esophageal cancer were analysed by single logistic regression and Logistic Regression Method. To analyze the rule of post-operative lymph node metastasis in different regions, according to the lymph node partition, in accordance with paragraphs of esophageal cancer in different groups. Results: Of the 102 patients after esophageal cancer surgery, who were confirmed by pathological examination, 50 cases had positive lymph node metastasis and 52 cases had negative, the lymph node metastasis rate was 49.0%. Lymph node metastasis rates of different depth, length and paragraph of tumor invasion had statistical difference (P < 0.05). The impact on lymph node metastasis rates of the different age and degree of differentiation had no statistical difference (P > 0.05). Multivariate analysis showed that the lesion length, depth of invasion and paragraph of tumor were meaningful factors affecting the lymph node metastasis. Of the 102 patients, 132 sites node metastasis were found by imaging study and histopathology with lower neck and supraclavicular node 59 (44.70%), upper mediastinum node 51 (38.64%), A-P windows node 1 (0.76%), anterior mediastinum node 1 (0.76%), Subcarinal node 5 (3.79%), paraesopha- geal node 3 (2.27%), hilar node 3 (2.27%), abdominal node 9 (6.82%). Conclusion: The length and depth of invasion, and paragraph of esophageal cancer are meaningful factors that affect the lymph node metastasis. The longer of lesion, deeper of infiltration and lower of paragraph, the easier to get independently lymph node metastasis. The postoperative lymph node metastasis was mainly distributed in the lower neck and supraclavicular region and upper mediastinal region, which is the focus of postoperative radiotherapy.

经颈侧胸锁乳突肌后下入路无注气腔镜甲状腺手术

目的探究经颈侧胸锁乳突肌后下入路无注气腔镜甲状腺手术的有效性与安全性。方法回顾性分析2022年12月~2023年3月收治的10例行经颈侧胸锁乳突肌后下入路无注气腔镜甲状腺手术患者,所有患者行术前穿刺活检考虑甲状腺乳头状癌,记录患者手术时间、出血量、术后恢复、并发症及随访情况。结果10例患者均顺利完成手术,平均手术时间4 h 39 min,平均出血量16 ml,平均术后住院时间4.6 d,无明显并发症,术后随访3个月,未诉明显颈部不适。结论经颈侧胸锁乳突肌后下入路无注气腔镜甲状腺手术安全性良好,患者术后恢复快,外观满意度高,颈部舒适感好。

重视对股骨颈骨折的骨缺损评估以优化手术方案决策

股骨颈骨折如何选择手术方案一般是以患者的年龄为主导——青壮年患者多首选内固定手术,而老年患者则首选关节置换[1]。但临床实践中却难以划定一个明确的年龄界线,对这些灰色年龄段的患者是选择内固定还是关节置换,是临床医师十分关注的问题[2]。评估内固定失败的风险是影响手术方案的重要因素。

胫骨近端骺板延长和骺板下延长治疗先天性胫骨假关节胫骨短缩的临床研究

目的评估儿童先天性胫骨假关节(congenital pseudarthrosis of the tibia,CPT)患者使用伊氏外固定装置行胫骨近端骺板下延长术和胫骨近端骺板延长术的愈合及并发症情况。方法回顾性分析湖南省儿童医院2012年2月至2020年6月间使用伊氏外固定装置行胫骨延长手术的61例CPT患儿临床资料。根据手术方式分组,行胫骨近端骺板下延长术者为A组(n=54),行胫骨近端骺板延长术者为B组(n=7)。选取延长后第1个月的X线片检查结果,采用Li分型评估骨痂质量。随访延长段骨痂质量及胫骨延长术后并发症情况。结果A组与B组手术时年龄[(87.0±5.9)个月比(115.2±15.2)个月]、延长长度[(5.3±0.2)cm比(7.0±1.6)cm]、愈合指数[(57.3±3.6)d/cm比(50.4±7.4)d/cm]比较,差异均无统计学意义(P>0.05);两组骨痂质量良好率(37/54比7/7)比较,差异无统计学意义(P=0.088);两组并发症发生率比较,针道感染(4/54比1/7)、胫骨机械轴线偏移(4/54比1/7)、腓骨提前愈合(3/54比0/7)、踝关节僵硬(2/54比1/7)、膝关节活动范围减小(7/54比1/7)的差异均无统计学意义(P>0.05)。结论胫骨近端骺板延长术与胫骨近端骺板下延长术均为CPT伴胫骨短缩的有效治疗方法,但胫骨近端骺板下延长存在腓骨提前愈合等并发症。

喉梭形细胞鳞状细胞癌的临床病理特点分析

目的 总结和分析喉梭形细胞鳞状细胞癌(spindle cell squamous carcinoma,Spc-SCC)的临床及病理特点,以期加深临床对该肿瘤的的认识,提升诊疗水平。方法 回顾性分析2017年4月~2021年4月于首都医科大学附属北京同仁医院耳鼻咽喉头颈外科诊治的12例Spc-SCC患者临床表现、病理及预后资料,10例行单纯手术治疗,1例术后行放、化疗,1例单纯放疗。利用SPSS软件,Kaplan-Meier法行统计学分析。结果 10例病理标本中可见梭形细胞/肉瘤样成分和上皮细胞成分共存,以梭形细胞成分为主,2例仅见梭形细胞成分。免疫组化染色均可见角蛋白CK的表达。随访3~63个月,2例患者死亡,1例死于局部复发大出血,1例为仅行放疗患者,余10例患者截至随访结束未见肿瘤复发及转移征象。1年、3年、5年生存率分别为91.7%、83.3%、83.3%。结论 病理学检查是Spc-SCC的主要确诊方式,手术切除为其主要的治疗手段。

儿童肾透明细胞肉瘤合并下腔静脉瘤栓手术1例报告并文献分析

目的探讨儿童肾透明细胞肉瘤合并下腔静脉瘤栓并瘤栓复发的临床特点、诊治及预后。方法回顾性分析湖南省儿童医院泌尿外科收治的1例肾透明细胞肉瘤并下腔静脉瘤栓患儿临床资料。以“clear cell sarcoma”、“thrombus”和“pediatric”为检索词检索PubMed、Web of Science数据库相关文献;以“透明细胞肉瘤”、“瘤栓”和“儿童”为检索词检索万方数据库及中国知网相关文献;剔除重复病例后进行文献复习,总结儿童肾透明细胞肉瘤的临床特征、手术方式及预后情况。结果本例患儿因“发热3 d、血尿3 d”入院,体查右上腹似可扪及一直径约10 cm肿块,质中,无压痛。腹部CT示肿块不均匀强化,腔静脉内低密度影,腹膜后多处淋巴结肿大。穿刺活检确诊肾透明细胞肉瘤,辅助化疗4个周期后行右肾肿瘤根治、腔静脉瘤栓取出术。2022年3月复查CT发现下腔静脉瘤栓复发,行瘤栓、部分下腔静脉切除术。首次手术时长10 h,术中出血量600 mL,切口一期愈合;病理检查结果:肾透明细胞肉瘤,肿瘤侵范未突破肾被膜,侵犯肾盂壁;肾窦及肾门血管未见肿瘤成分;输尿管切缘及右肾旁淋巴结未见肿瘤细胞,术后放疗6个周期、化疗5个周期;第2次手术时长8 h,出血量300 mL,术后化疗5个周期。病理检查示下腔静脉瘤栓为肿瘤成分。目前已随访至术后6个月,患儿无静脉曲张、下肢水肿等腔静脉梗阻表现,肾功能正常。复查CT未见肿瘤复发及明显肿瘤遗存。共获得9篇符合要求的文献,报道11例儿童肾透明细胞肉瘤合并下腔静脉瘤栓患儿,其中男7例,女4例;平均年龄7岁10个月(1岁11个月至14岁);左肾肿瘤4例,右肾7例;8例瘤栓侵入右心房,9例行肾肿瘤根治切除及腔静脉切开取栓,其中5例在体外循环下取栓。中位随访时间16个月(1.5~36个月),3例出现转移或复发。结论对于肾透明细胞肉瘤合并腔静脉瘤栓患儿,可选择经腔静脉切开取栓;瘤栓复发时,如证实侧支循环畅通,可行瘤栓与部分下腔静脉一同切除。

改良胫骨横向骨搬运技术治疗Wagner 3~4级糖尿病足患者的效果研究

背景糖尿病足是一种严重的糖尿病慢性并发症,胫骨横向骨搬运(TTT)技术可促进血管组织再生,改善微循环,在治疗糖尿病足溃疡中取得良好效果,但传统TTT技术并发症较多,需对该技术进行改良来减少术后并发症。目的探讨改良TTT技术即骨与骨膜联合搬运治疗Wagner 3~4级糖尿病足患者的疗效。方法回顾性分析2018年1月—2021年5月于烟台毓璜顶医院手足外科应用改良TTT技术治疗的117例糖尿病足患者的临床资料,收集患者术后保足情况、功能性保肢情况、大截肢情况和溃疡愈合时间、并发症、足部皮温改善情况、静息痛情况及术前、术后CT血管造影(CTA)资料。随访时间截至2022-03-31。结果随访时间5.5~24.0个月,平均(14.21±4.06)个月。术后保足率(未截肢或踝关节以下截肢)为95.73%(112/117),功能性保肢率(未截肢或中足中段以远部位小截肢)为83.76%(98/117),大截肢率(踝关节以上截肢)为4.27%(5/117),除截肢患者外其余患者术后溃疡愈合良好,愈合时间6.0~14.5周,平均愈合时间为(9.07±2.02)周。患者术后1、2、4、8周足温高于术前(P<0.01);静息痛患者35例,静息痛患者术后1、2、4、8周视觉模拟评分(VAS)低于术前(P<0.01);CTA显示70.34%(94/117)的患者术后血管情况好转、微血管数量增加、足部血管网重建;在骨搬运过程中并发症发生率为11.97%(14/117),其中截骨区域皮缘坏死、下肢静脉血栓、钉道感染的发生率分别为5.98%(7/117)、4.27%(5/117)、1.71%(2/117)。结论改良TTT技术将骨与骨膜联合搬运可以通过刺激下肢微循环的重建促进创面愈合,短期内有效缓解糖尿病足患者静息痛,改善足部温度,且并发症发生率低,为治疗糖尿病足提供了一种有效手段。